Inventor
DU WU
CN17 patents
⚠️ This page may combine multiple inventors who share the name “DU WU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HINOVA PHARMACEUTICALS INC
7 patentsUS11926618B2Mar 12, 2024
Halogen-substituted phenylate compound and applications thereof
HINOVA PHARMACEUTICALS INC0 citations62
US12194040B2Jan 14, 2025
FAK inhibitor and drug combination thereof
HINOVA PHARMACEUTICALS INC0 citations60
US11891379B2Feb 6, 2024
Deuterated Defactinib compound and use thereof
HINOVA PHARMACEUTICALS INC0 citations60
US11447477B2Sep 20, 2022
Indoleamine-2,3-dioxygenase inhibitor, the preparative method and the use thereof
HINOVA PHARMACEUTICALS INC0 citations54
US11753392B2Sep 12, 2023
Method for synthesis of deuterated amide and deuterated sulfonamide
HINOVA PHARMACEUTICALS INC0 citations46
US11591301B2Feb 28, 2023
Indoleamine-2,3-dioxygenase inhibitor, preparation method therefor and use thereof
HINOVA PHARMACEUTICALS INC0 citations45
US10450274B2Oct 22, 2019
Quinoline compounds, preparation methods thereof, and uses thereof as urate transporter inhibitor drug
HINOVA PHARMACEUTICALS INC0 citations39
PTC THERAPEUTICS INC
5 patentsUS10428050B2Oct 1, 2019
Substituted reverse pyrimidine Bmi-1 inhibitors
PTC THERAPEUTICS INC4 citations71
US10370371B2Aug 6, 2019
Substituted pyrimidine Bmi-1 inhibitors
PTC THERAPEUTICS INC3 citations71
US11180483B2Nov 23, 2021
Substituted reverse pyrimidine Bmi-1 inhibitors
PTC THERAPEUTICS INC1 citations61
US10584115B2Mar 10, 2020
Substituted pyridine and pyrazine BMI-1 inhibitors
PTC THERAPEUTICS INC1 citations61
US9975878B2May 22, 2018
Substituted triazine BMI-1 inhibitors
PTC THERAPEUTICS INC0 citations40